Plus   Neg

Biomerica Inc. (BMRA) Surges To New High On Chinese Approval

Biomerica Inc. (BMRA) announced Wednesday morning that it has received approval from the China Food and Drug Administration for its EZ Detect colorectal screening test.

Biomerica gapped up at the open Wednesday and has been rising for the majority of early trade on strong volume and is now up 4.43 at $8.83. The stock has soared to a new high for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

$5 And Under

0 Articles
Follow RTT